Hui Kong Selected Research

N-vinyl-2-pyrrolidinone

8/2016	Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line.
1/2014	An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Kong Research Topics

Disease

20	Inflammation (Inflammations) 04/2022 - 11/2014
16	Hypoxia (Hypoxemia) 10/2021 - 04/2015
14	Neoplasms (Cancer) 01/2019 - 10/2003
9	Pulmonary Arterial Hypertension 01/2022 - 01/2015
9	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2014
8	Pulmonary Hypertension 01/2020 - 05/2013
7	Vascular Remodeling 01/2020 - 05/2013
5	Hypersensitivity (Allergy) 12/2021 - 08/2008
5	Infections 01/2021 - 01/2019
4	Acute Lung Injury 01/2022 - 01/2019
4	Stroke (Strokes) 08/2021 - 12/2008
4	Brain Ischemia (Cerebral Ischemia) 08/2021 - 09/2013
4	Hypertrophy 01/2020 - 06/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2014
3	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2022 - 10/2020
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2021 - 12/2008
3	Fibrosis (Cirrhosis) 04/2021 - 01/2018
3	Stomach Ulcer (Gastric Ulcer) 03/2021 - 01/2021
3	Necrosis 01/2021 - 06/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 09/2015
3	Right Ventricular Hypertrophy 01/2020 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 03/2019 - 01/2018
3	Adenocarcinoma of Lung 08/2016 - 09/2015
3	Hyperplasia 08/2015 - 03/2005
3	Inverted Papilloma 09/2014 - 03/2005
2	Osteoarthritis 10/2022 - 01/2021
2	Hyperglycemia 04/2022 - 12/2018
2	COVID-19 01/2021 - 01/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 03/2015
2	Asthma (Bronchial Asthma) 04/2020 - 08/2015
2	Gastritis 01/2020 - 01/2018
2	Gouty Arthritis 11/2019 - 11/2019
2	Lung Injury 06/2019 - 01/2019
2	Pathologic Processes 08/2018 - 01/2015
2	Neoplasm Metastasis (Metastasis) 08/2016 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 08/2016 - 08/2016

Drug/Important Bio-Agent (IBA)

13	CarbonIBA 01/2022 - 11/2019
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2003
11	MonocrotalineIBA 01/2022 - 05/2013
9	Interleukin-6 (Interleukin 6)IBA 04/2022 - 12/2016
7	Biological ProductsIBA 11/2021 - 12/2003
6	Pharmaceutical PreparationsIBA 04/2021 - 12/2003
5	AntioxidantsIBA 10/2021 - 08/2015
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2015
5	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 08/2015
5	KATP ChannelsIBA 07/2019 - 08/2015
5	CytokinesIBA 01/2019 - 12/2012
4	LipopolysaccharidesIBA 01/2022 - 01/2016
4	InterleukinsIBA 01/2021 - 09/2015
4	EnzymesIBA 07/2019 - 12/2016
3	Adenosine Triphosphate (ATP)IBA 04/2022 - 08/2015
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 08/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2021 - 12/2016
3	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2016
3	fasudil (AT 877)IBA 01/2021 - 01/2019
3	Liraglutide FDA Link 10/2020 - 01/2019
3	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2020 - 01/2018
3	N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA 07/2019 - 08/2015
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 01/2018
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 01/2018
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 06/2012
3	InflammasomesIBA 01/2018 - 09/2015
3	tetrandrineIBA 01/2017 - 01/2014
3	Aquaporins (Water Channels)IBA 06/2014 - 08/2008
2	peoniflorinIBA 01/2022 - 01/2020
2	Neuroprotective AgentsIBA 08/2021 - 12/2008
2	RNA (Ribonucleic Acid)IBA 08/2021 - 12/2016
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2021
2	rho-Associated KinasesIBA 01/2021 - 06/2019
2	Semaxinib (SU5416)IBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 01/2021 - 07/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 12/2016
2	SaltsIBA 01/2021 - 01/2019
2	CalciumIBA 01/2021 - 01/2021
2	Hormones (Hormone)IBA 01/2021 - 02/2012
2	Oxygen (Dioxygen)IBA 06/2020 - 04/2015
2	Immunoglobulin E (IgE)IBA 04/2020 - 10/2013
2	AdrenomedullinIBA 01/2020 - 10/2018
2	CollagenIBA 01/2020 - 08/2015
2	VenomsIBA 12/2019 - 01/2019
2	Uric Acid (Urate)IBA 11/2019 - 11/2019
2	Xanthine OxidaseIBA 11/2019 - 11/2019
2	Hematoxylin (Haematoxylon)IBA 06/2019 - 03/2014
2	ImmunosorbentsIBA 06/2019 - 07/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 06/2019 - 03/2014
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 10/2018
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 01/2019
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 10/2018
2	Nanoparticle Drug Delivery SystemIBA 01/2019 - 08/2016
2	Becaplermin (PDGF-BB)FDA Link 01/2019 - 12/2016
2	Shikimic AcidIBA 11/2018 - 09/2013
2	propylene (propene)IBA 11/2018 - 09/2013
2	CaspasesIBA 12/2016 - 11/2016
2	Indicators and Reagents (Reagents)IBA 12/2016 - 08/2016
2	caprolactoneIBA 08/2016 - 01/2014
2	N-vinyl-2-pyrrolidinoneIBA 08/2016 - 01/2014
2	NucleotidesIBA 04/2016 - 10/2003

Therapy/Procedure

7	Therapeutics 08/2021 - 10/2008
4	Drug Therapy (Chemotherapy) 10/2021 - 06/2016
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2021 - 12/2018